Coagulant potentials of emicizumab in the plasmas from infant and toddler patients with hemophilia A.

Masahiro TakeyamaNaoki MatsumotoHiroto AbeSuguru HaradaKenichi OgiwaraShoko FurukawaNaruto ShimonishiYuto NakajimaKoji YadaTetsuhiro SoedaKeiji Nogami

Published in: Pediatric blood & cancer (2023)

Emicizumab could improve coagulant potential in plasmas from infant/toddler patients with hemophilia A.

Keyphrases

human health
risk assessment
climate change